Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1938-1943

  Hallemeier, Christopher L ^a   Choo, Richard ^a   Davis, Brian J ^a   Pisansky, Thomas M ^a   Gunderson, Leonard L ^b   Leibovich, Bradley C ^a   Haddock, Michael G ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Combined modality therapy; Intraoperative radiotherapy; Nephrectomy; Renal cell carcinoma

Indexed keywords

COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; INTRA-OPERATIVE; INTRAOPERATIVE RADIOTHERAPY; KAPLAN-MEIER METHOD; LONG-TERM OUTCOME; LYMPH NODE; MULTI-MODALITY; MULTIMODALITY THERAPY; NATIONAL CANCER INSTITUTE; NEPHRECTOMY; OVERALL SURVIVAL; RENAL CELL CARCINOMA; SURGICAL RESECTION; TUMOR BED;

RADIOTHERAPY; TOXICITY;

SURGERY;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PANCREAS PSEUDOCYST; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER; TREATMENT OUTCOME; TUMOR LOCALIZATION; ULCER PERFORATION;

ADULT; AGED; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 84858665234     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.026     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Bruno JJ 2nd, Snyder ME, Motzer RJ, et al. Renal cell carcinoma local recurrences: Impact of surgical treatment and concomitant metastasis on survival. BJU Int 2006;97:933-938.
3. Itano NB, Blute ML, Spotts B, et al. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000;164:322-325. (Pubitemid 30481915)
4. Margulis V, McDonald M, Tamboli P, et al. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 2009;181:2044-2051.
5. Schrodter S, Hakenberg OW, Manseck A, et al. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. J Urol 2002;167: 1630-1633. (Pubitemid 34240687)
6. Gogus C, Baltaci S, Beduk Y, et al. Isolated local recurrence of renal cell carcinoma after radical nephrectomy: Experience with 10 cases. Urology 2003;61:926-929. (Pubitemid 36547730)
7. Master VA, Gottschalk AR, Kane C, et al. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol 2005;174:473-477. discussion 477.
8. Esrig D, Ahlering TE, Lieskovsky G, et al. Experience with fossa recurrence of renal cell carcinoma. J Urol 1992;147: 1491-1494.
9. Tanguay S, Pisters LL, Lawrence DD, et al. Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol 1996; 155:26-29. (Pubitemid 126426424)
10. Rabinovitch RA, Zelefsky MJ, Gaynor JJ, et al. Patterns of failure following surgical resection of renal cell carcinoma: Implications for adjuvant local and systemic therapy. J Clin Oncol 1994;12:206-212. (Pubitemid 24020641)
11. Frydenberg M, Gunderson L, Hahn G, et al. Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies. J Urol 1994;152:15-21. (Pubitemid 24175689)
12. Gunderson LL, Nelson H, Martenson JA, et al. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum 1996;39:1379-1395. (Pubitemid 26422599)
13. Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002;52:469-475. (Pubitemid 34170851)
14. Miller RC, Haddock MG, Gunderson LL, et al. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus 2006;19:487-495. (Pubitemid 44644687)
15. Dowdy SC, Mariani A, Cliby WA, et al. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: Technique and analysis of outcomes. Gynecol Oncol 2006;101:280-286.
16. Haddock MG, Gunderson LL, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys 2001;49: 1267-1274. (Pubitemid 32294307)
17. Haddock MG, Miller RC, Nelson H, et al. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 2011;79:143-150.
18. Tepper JE, Gunderson LL, Orlow E, et al. Complications of intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1984;10:1831-1839. (Pubitemid 15201576)
19. National Cancer Institute. Common Toxicity Criteria. Version 4.02. Rockville, MD: National Cancer Institute. 2011.
20. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
21. Eble MJ, Stahler G, Wannenmacher M. IORT for locally advanced or recurrent renal cell carcinoma. Front Radiat Ther Oncol 1997;31:253-255.
22. Santos M, Ucar A, Ramos H, et al. [Intraoperative radiotherapy in locally advanced carcinoma of the kidney: Initial experience]. Actas Urol Esp 1989;13:36-40.
23. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-124. (Pubitemid 46089672)
24. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356:125-134. (Pubitemid 46089673)
25. Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007;356:2271-2281. (Pubitemid 46849157)
26. Yang JC, Haworth L, Sherry RM, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003;349: 427-434. (Pubitemid 36910021)
27. Wersall PJ, Blomgren H, Lax I, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005;77:88-95. (Pubitemid 41503395)
28. McLaughlin CA, Chen MY, Torti FM, et al. Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomy. AJR Am J Roentgenol 2003;181: 93-94. (Pubitemid 36741466)
29. Svedman C, Sandstrom P, Pisa P, et al. A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 2006;45: 870-875. (Pubitemid 44423134)